View Item 
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        •   Utrecht University Student Theses Repository Home
        • UU Theses Repository
        • Theses
        • View Item
        JavaScript is disabled for your browser. Some features of this site may not work without it.

        Browse

        All of UU Student Theses RepositoryBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

        Octreotide and Delayed Bleeding after Endoscopic Papillectomy: a Propensity Score Matching Analysis

        Thumbnail
        View/Open
        Octreotide and Delayed Bleeding after Endoscopic Papillectomy- a Propensity Score Matching Analysis.pdf (649.3Kb)
        Publication date
        2024
        Author
        Leur, Cecile van de
        Metadata
        Show full item record
        Summary
        Background - Endoscopic papillectomy (EP) is widely used for managing ampullary lesions but carries risks of adverse events like delayed bleeding and pancreatitis. Octreotide has been proposed as a preventive measure for these complications, but its efficacy remains uncertain. Methods - A retrospective cohort study was conducted at University Medical Center Utrecht from 2015 to 2023. Risk factors for adverse events were identified using logistic regression. The impact of octreotide prophylaxis was assessed using propensity score matching. Results - A total of 69 ampullary lesions in 50 patients were resected, achieving complete endoscopic resection in 92% of primary procedures (median lesion size 15mm, IQR 10- 31.5mm). EP-related adverse events occurred in 45% of procedures, with delayed bleeding in 28% of cases. Management included endoscopic hemostasis (n=7) and embolization (n=2). Older age (OR 1.12, 95% CI 1.02-1.23, p=0.014) and lesion size >30mm (OR 7.43, 95% CI 1.12- 49.36, p=0.038) were risk factors for delayed bleeding. Octreotide administration in 19 procedures did not reduce delayed bleeding risk. Pancreatitis (17%) and delayed perforation (7%) resulted in mortality in two patients (4%). Placement of a pancreatic duct stent significantly correlated with lower post-procedural pancreatitis incidence (OR 0.15, 95% CI 0.033-0.71, p=0.017). Tumor recurrence was observed in 38% of patients, and final endoscopic success after repeat EP procedures was achieved in 70% of patients. Conclusion - EP effectively treats ampullary adenomas but poses notable risks, including pancreatitis and delayed bleeding. Octreotide prophylaxis does not significantly reduce delayed bleeding incidence. Further research is necessary to optimize complication prevention.
        URI
        https://studenttheses.uu.nl/handle/20.500.12932/48198
        Collections
        • Theses
        Utrecht university logo